HUM vs IMRX
Humana Inc (HUM) versus Immuneering Corp (IMRX) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. IMRX currently screens at market cap $124.2M.
Not investment advice. Open the HUM and IMRX stock pages for the full models.
Not investment advice.